Opportunity
DIBBS #SPE2DP-26-T-3904
DLA Solicitation for Moxifloxacin Hydrochloride Tablets (400 mg, 30-count)
Posted
June 25, 2026
Respond By
June 30, 2026
Identifier
SPE2DP-26-T-3904
NAICS
424210
This opportunity involves the Defense Logistics Agency Troop Support Medical Supply Chain Pharmacy FSA seeking Moxifloxacin Hydrochloride Tablets for pharmaceutical supply needs. - Government Buyer: - Defense Logistics Agency (DLA) - Sub-agency: DLA Troop Support Medical Supply Chain Pharmacy FSA - Office: Philadelphia, PA - OEMs (Original Equipment Manufacturers): - TEVA PHARMACEUTICALS USA, INC. (part number NDC00093-7387-56) - RISING PHARMA HOLDINGS, INC. (part number NDC57237-0156-30) - Products Requested: - Moxifloxacin Hydrochloride Tablets, 400 mg, 30 tablets per bottle - National Stock Number (NSN): 6505-01-503-4772 - Total quantity: 15 bottles (12 bottles under one line item, 3 bottles under another) - Must be FDA regulated and comply with Medical Marking Standard No. 1A and MIL-STD-2073-1E - Packaging and marking per medical and military standards - Notable Requirements: - Only products from the approved OEMs or equivalent are acceptable - Delivery required within 5 days after order - Compliance with FDA regulations and specific packaging/marking standards
Description
MOXIFLOXACIN HYDROC (QTY: 3, NSN: 6505-01-503-4772, Purchase Request: 7017285555) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.
MOXIFLOXACIN HYDROC (QTY: 12, NSN: 6505-01-503-4772, Purchase Request: 7017278715) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.